GnRH receptor and apoptotic signaling

Vitamins and Hormones

Volumn 59, Issue , 2000, Pages 1-33

  Imai, Atsushi ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; FAS ANTIGEN; FERTILITY PROMOTING AGENT; GONADORELIN; GONADORELIN RECEPTOR; PHOSPHATIDYLINOSITOL; PROTEIN TYROSINE PHOSPHATASE;

APOPTOSIS; CELL MEMBRANE; FEMALE; HUMAN; NEOPLASM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANTIGENS, CD95; APOPTOSIS; CELL MEMBRANE; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; PHOSPHATIDYLINOSITOLS; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, LHRH; SIGNAL TRANSDUCTION;

EID: 0033630476     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0083-6729(00)59002-5     Document Type: Review

References (186)

1. R. Ackerman G. Johnson E. Van Kirk A. Asirvatham W. Murdoch Induction of apoptotic or lytic death in an ovarian adenocarcinoma cell line by antibodies generated against a synthetic N-terminal extracellular domain gonadotropinreleasing hormone receptor peptide Cancer Lett. 81 1994 177 184
2. D. Aharoni A. Dantes M. Oren A. Amsterdam cAMP-mediated signals as determinants for apoptosis in primary granulosa cells Exp. Cell Res. 218 1995 271 282
3. R. Allen M. Cluck D. Agrawal Mechanisms controlling cellular suicide: Role of Bcl-2 and caspases Cell. Mol. Life Sci. 54 1998 427 445
4. A. Amsterdam A. Dantes M. Liscovitch Role of phospholipase-D and phosphatidic acid in mediating gonadotropin-releasing hormone-induced inhibition of preantral granulosa cell differentiation Endocrinology 135 1994 1205 1211
5. C. Andreu F. Parborell S. Vanzulli H. Chemes M. Tesone Regulation of follicular luteinization by a gonadotropin-releasing hormone agonist: Relationship between steroidogenesis and apoptosis Mol. Reprod. Dev. 51 1998 287 294
6. 3 rat pituitary cells J. Biol. Chem. 267 1992. 24983 24988
7. A. Arcaro M. Wymann Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: The role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses Biochem. J. 296 1993 297 301
8. A. Bamberger H. Schulte I. Thuneke I. Erdmann C. Bamberger A. Asa Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells J. Clin. Endocrinol. Metab. 82 1997 3173 3175
9. T. Bilderback R. Grigsby R. Dobrowsky Association of p75(NTR) with caveolin and localization of neurotrophin-induced sphingomyelin hydrolysis to caveolae J. Biol. Chem. 272 1997 10922 10927
10. H. Billig I. Furuta A. Hsueh Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: Biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulosa cells Endocrinology 134 1996 245 252
11. L. Birnbaumer Receptor to effector coupling through G proteins: Roles for βγ dimers as well as a subunits Cell 71 1992 1063 1072
12. Z. Blumenfeld N. Haim Prevention of gonadal damage during cytotoxic therapy Ann. Med. 29 1997 199 206
13. Z. Blumenfeld I. Avivi S. Linn R. Epelbaum M. Ben-Shahar N. Haim Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy Hum. Reprod. 11 1997 1620 1626
14. H. Bruckner B. Motwani Treatment of advanced refractory ovarian carcinoma with a gonadotropin-releasing hormone analogue Am. J. Obstet. Gynecol. 161 1992 1216 1218
15. L. Cantley K. Auger C. Carpenter B. Duckworth A. Graziani R. Kapeller S. Soltoff Oncogens and signal transduction Cell 64 1991 281 302
16. C. Carpenter L. Cantley Phosphoinositide kinases Biochemistry 29 1990 11147 11156
17. J. Chang J. Graeter K. Catt Dynamic actions of arachidonic acid and protein kinase C in pituitary stimulation by gonadotropin-releasing hormone Endocrinology 120 1987 1837 1845
18. E. Chatzaki C. Bax K. Eidne L. Anderson J. Grudzinskas C. Gallagher The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor Cancer Res. 56 1996 2059 2065
19. M. Cifone R. De Maria P. Roncaioli M. Rippo M. Azuma L. Lanier A. Santoni R. Testi Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase J. Exp. Med. 177 1994 1547 1552
20. M. Cifone P. Roncaioli R. De Maria G. Camarda A. Santoni G. Ruberti R. Testi Multiple pathways originate at the Fas/Apo-1 (CD95) receptor: Sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal EMBO J. 14 1995 5859 5868
21. G. Cohen R. Ren D. Baltimore Modular binding domains in signal transduction proteins Cell 80 1995 237 248
22. A. Comaru-Schally W. Brannan A. Schally M. Colcolough M. Monga Efficacy and safety of luteinizing hormone-releasing hormone antagonist cetrorelix in the treatment of symptomatic benign prostatic hyperplasia J. Clin. Endocrinol. Metab. 83 1998 3826 3831
23. B.R. Conklin H.R. Bourne Structural elements of Ga subunits that interact with Gβγ, receptors and effectors Cell 73 1993 631 641
24. P. Conn W. Crowley Jr. Gonadotropin-releasing hormone and its analogs Annu. Rev. Med. 45 1994 391 405
25. P. Conn J. Janovick D. Stanislaus D. Kuphal L. Jennes Molecular and cellular bases of gonadotropin-releasing hormone action in the pituitary and central nervous system Vitam. Horm. 50 1995 151 214
26. D. Crawford Hormonal therapy of prostatic carcinoma Oncology 66 1990 1035 1038
27. S. Dethlefsen G. Raab M. Moses R. Adam M. Klagsbrun M. Freeman Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C J. Cell. Biochem. 69 1998 143 153
28. N. Dhanasekaran L. Heasley G. Johnson G protein-coupled receptor systems involved in cell growth and oncogenesis Endocr Rev. 16 1995 259 270
29. J. Dhein P. Daniel B. Trauth A. Oehn P. Moller P. Krammer Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens J. Immunol. 149 1992 3166 3173
30. N. Divecha R. Irvine Phospholipid signaling Cell 80 1995 269 278
31. R. Dobrowsky Y. Hannun Ceramide stimulates a cytosolic protein phosphatase J. Biol. Chem. 267 1992 5048 5051
32. D. Dondi R. Moretti M. Marelli M. Motta P. Limonta Growth factors in steroid-responsive prostatic tumor cells Steroids 61 1996 222 225
33. Q. Dou Y. Zhao R. Tarnuzzer H. Rong S. Williams G. Schultz N. Chegini Suppression of transforming growth factor-β (TGFβ) and TGFβ receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy J. Clin. Endocrinol. Metab. 81 1996 3222 3230
34. G. Emons O. Ortmann M. Becker G. Irmaer B. Springer R. Laun F. Hölzel K. Schulz A. Schally High affinity binding and direct antiproliferative effects of LH-RH analogues in human ovarian cancer cell lines Cancer Res. 54 1993 5439 5446
35. G. Emons B. Schröder O. Ortmann S. Westphalen K. Schulz A. Schally High affinity binding and direct antiproliferative effect of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines J. Clin. Endocrinol. Metab. 77 1993 1458 1464
36. G. Emons A.V. Schally The use of luteinizing hormone releasing hormone agonists and antagonists in gynecological cancers Hum. Reprod. Update 9 1994 1364 1379
37. J. Exton Phospholipase D: Enzymology, mechanisms of regulation, and function Physiol Rev. 77 1997 303 320
38. W. Fantl D. Johnson L. Williams Signalling by receptor tyrosine kinases Annu. Rev. Biochem. 62 1993 453 481
39. D. Farschon C. Couture T. Mustelin D. Newmeyer Temporal phases in apoptosis defined by the actions of Src homology 2 domains, ceramide, Bcl-2, interleukin-1beta converting enzyme family proteases, and a dense membrane fraction J. Cell Biol. 137 1997 1117 1125
40. E. Fischer H. Charbonneau N. Tonks Protein tyrosine phosphatases: A diverse family of intracellular and transmembrane enzymes Science 253 1991 401 406
41. T. Florio M. Pan B. Newman R. Hershberger O. Civelli P. Stork Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity J. Biol. Chem. 267 1992 24169 24172
42. M. Flucker L. Marshall S. Monroe R. Jaffe Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle J. Clin. Endocrinol. Metab. 72 1991 912 919
43. C. Friesen I. Herr P. Krammer K. Debatin Involvement of the CD95 (Apo1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells Nat. Med. 2 1996 574 577
44. H. Friess M. Buchler K. Kiesel M. Kruger H. Berger LH-RH receptors in the human pancreas: Basis for antihormonal treatment in ductal carcinoma of the pancreas Int. J. Pancreatol. 10 1991 151 159
45. C. Gallagher R. Oliver D. Oram C. Fowler P. Blanke B. Mantell M. Slevin H. Hope-Sone Anew treatment for endometrial cancer with gonadotropin releasing-hormone analogue Br. J. Obstet. Gynecol. 98 1991 1037 1041
46. +, hormonal untreated breast cancer patient Gynecol. Endocrinol. 7 Suppl. 2 1993 68 69
47. A. Gearing P. Beckett M. Christodoulou M. Churchill J. Clements A. Davidson A. Drummond W. Galloway R. Gilbert J. Gordon Processing of tumor necrosis factor-α precursor by metalloproteinases Nature 370 1994 555 557
48. M. Ghahremani A. Foghi J. Dorrington Activation of Fas ligand/receptor system kills ovarian cancer cell lines by an apoptotic mechanism Gynecol. Oncol. 70 1998 275 281
49. B. Gill H. Nishikata G. Chan T. Delovitch A. Ochi Fas antigen and sphingomyelin-ceramide turnover-mediated signaling: Role in life and death of lymphocytes Immunol. Rev. 142 1994 113 124
50. J. Gomez-Cambronero P. Keire Phospholipase D: A novel major player in signal transduction Cell Signal 10 1998 387 397
51. D. Gonzalez-Barcena M. Ibarra-Olmos F. Garcia-Carrasco C. Gutierrez-Samperio A. Comaru-Schally A. Schally Influence of D-Trp-6-LH-RH on the survival time in patients with advanced pancreatic cancer Biomed. Pharmacother. 43 1989 313 317
52. B. Gonzalez-Barcena M. Vadillo-Buenfil A. Cortez-Morales M. Fuentes-Garcia I. Cardenas-Cornejo A. Comaru-Schally A. Schally LHRH antagonist SB-75 (Cetrorelix) as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord Urology 45 1995 275 281
53. C. Gratas Y. Tohma C. Barnas P. Taniere P. Hainaut H. Ohgaki Upregulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer Cancer Res. 58 1998 2057 2062
54. N. Hakuno T. Koji T. Yano Y. Taketani Fas/APO-1/CD-95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia Endocrinology 137 1996 1938 1948
55. K. Hammond P. Bex E. Mohamed N. Levy Phosphoamino acid phosphatases in normal and cancerous tissues of the human uterus, cervix and ovary Arch. Int. Physiol. Biochim. Biophys. 100 1992 105 107
56. Y. Hannun The sphingomyelin cycle and the second messenger function of ceramide J. Biol. Chem. 269 1995 3125 3128
57. Y. Hannun Functions of ceramide in coordinating cellular responses to stress Science 274 1996 1855 1859
58. C. Heldin Dimerization of cell surface receptors in signal transduction Cell 80 1995 213 233
59. I. Herr D. Whilhelm T. Böhler P. Angel K. Debatin Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis EMBO J 16 1997 6200 6208
60. E. Hertervig A. Nilsson L. Nyberg R. Duan Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma Cancer 79 1997 448 453
61. S. Hetts To die or not to die: An overview of apoptosis and its role in disease JAMA 279 1998 300 307
62. T. Higashijima A. Kataoka T. Nishida M. Yakushiji Gonadotropinreleasing hormone agonist therapy induces apoptosis in uterine leiomyoma Eur. J. Obstet. Gynecol. Reprod. Biol. 68 1996 169 173
63. K. Horinouchi S. Erlich D. Perl K. Ferlinz C. Bisgaier K. Sandhoff R. Desnick C. Stewart E. Schuchman Acid sphingomyelinase deficient mice: Amodel of types A and B Niemann-Pick disease Natl. Genet. 10 1995 288 293
64. K. Hsieh T. Martin Thyrotropin-releasing hormone and gonadotropin-releasing hormone receptors activate phospholipase C by coupling to guanosine triphosphate-binding proteins Gq and G11 Mol. Endocrinol. 6 1992 1673 1681
65. A. Hsueh K. Eisenhauer S. Chun S. Hsu H. Billig Gonadal cell apoptosis Recent Prog. Horm. Res. 51 1996 433 455
66. S. Huang C. Chou Y. Lin Y. Tsai K. Hsu C. Liu K. Huang Enhanced deoxyribonucleic acid damage and repair but unchanged apoptosis in uterine leiomyomas treated with gonadotropin-releasing hormone agonist Am. J. Obstet. Gynecol. 177 1998 417 424
67. W. Huckle P. Conn Molecular mechanism of gonadotropin releasing hormone action II: The effector system Endocr Rev. 9 1988 387 395
68. H. Hug Fas-mediated apoptosis in tumor formation and defense Biol. Chem. 378 1997 1405 1412
69. T. Hunter Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling Cell 80 1995 225 236
70. N. Husain E. Chiocca N. Rainov D. Louis N. Zervas Coexpression of Fas ligand in malignant glial tumors and cell lines Acta Neuropathol. 95 1998 287 290
71. A. Imai K. Iida T. Tamaya Tight coupling of gonadotropin-releasing hormone receptor to stimulated phosphoinositide turnover and antigonadotropic action in granulosa cells Gynecol. Obstet. Invest. 33 1992 36 41
72. A. Imai K. Iida T. Tamaya Gonadotropin-releasing hormone has a biphasic action on aromatase activity through protein kinase C in granulosa cells Int. J. Fertil. 38 1993 50 56
73. A. Imai T. Ohno T. Furui K. Takahashi T. Matsuda T. Tamaya Gonadotropin-releasing hormone stimulates phospholipase C but not protein phosphorylation/dephosphorylation in plasma membrane from human epithelial ovarian cancer Int. J. Gynecol. Cancer 3 1993 311 317
74. A. Imai T. Ohno K. Iida T. Fuseya T. Furui T. Tamaya Gonadotropinreleasing hormone receptor in gynecologic tumors: Frequent expression in adenocarcinoma histologic types Cancer 74 1994 2555 2561
75. A. Imai S. Horibe H. Takagi T. Fuseya T. Tamaya Signal transduction of GnRH receptor in the reproductive tract tumor Endocr. J. 43 1996 249 260
76. A. Imai H. Takagi T. Furui S. Horibe T. Fuseya T. Tamaya Evidence for coupling of phosphotyrosine phosphatase to gonadotropin-releasing hormone receptor in ovarian carcinoma membrane Cancer 77 1996 132 137
77. A. Imai H. Takagi S. Horibe T. Fuseya T. Tamaya Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors J. Clin. Endocrinol. Metab. 81 1996 3249 3253
78. A. Imai S. Horibe A. Takagi T. Ohno T. Tamaya Frequent expression of Fas in gonadotropin-releasing hormone receptor-bearing tumors Eur. J. Obstet. Gynecol. Reprod. Biol. 74 1997 73 78
79. A. Imai S. Horibe A. Takagi T. Tamaya Gi protein activation of gonadotropin-releasing hormone-mediated protein dephosphorylation in human endometrial carcinoma Am. J. Obstet. Gynecol. 176 1997 371 376
80. A. Imai A. Takagi S. Horibe H. Takagi T. Tamaya Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: Possible mechanism for hormonal control of apoptotic cell death J. Clin. Endocrinol. Metab. 83 1998 427 431
81. A. Imai A. Takagi S. Horibe H. Takagi T. Tamaya Fas and Fas ligand system may mediate antiproliferative activity of gonadotropin-releasing hormone receptor in endometrial cancer cells Int. J. Oncol. 13 1998 97 100
82. T. Ingebritsen Phosphotyrosyl-protein phosphatases II: Identification and characterization of two heat-stable protein inhibitors J. Biol. Chem. 264 1989 7754 7759
83. G. Irmer C. Bürger O. Ortmann K. Schulz G. Emons Expression of luteinizing hormone releasing hormone and its mRNA in human endometrial cancer cell lines J. Clin. Endocrinol. Metab. 79 1994 916 919
84. G. Irmer C. Burger R. Muller O. Ortmann U. Peter S. Kakar J. Neil K. Schulz G. Emons Expression of the messenger RNAs for luteinizing hormonereleasing hormone (LH-RH) and its receptor in human ovarian epithelial carcinoma Cancer Res. 55 1995 817 822
85. N. Itoh S. Yonehara A. Ishii M. Yonehara S. Mizushima M. Sameshima A. Hase Y. Seto S. Nagata The polypeptide encoded by the cDNAfor human cell surface antigen Fas can mediate apoptosis Cell 66 1991 233 243
86. P. Iversen S. Sucius R. Sylvester I. Christensen L. Denis Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer Cancer 66 1990 1067 1073
87. W. Jarvis R. Kolesnick F. Fornari R. Traylor D. Gerwitz S. Grabt Induction of apoptotic damage and cell death by activation of the sphingomyelin pathway Proc. Natl. Acad. Sci. USA 91 1995 73 77
88. A. Kaipia S. Chun K. Eisenhauer A. Hsueh Tumor necrosis factor-alpha and its second messenger, ceramide, stimulate apoptosis in cultured ovarian follicles Endocrinology 137 1996 4864 4870
89. U. Kaiser R. Katzenellenbogen P. Conn W. Chin Evidence that signalling pathways by which thyrotropin-releasing hormone and gonadotropin-releasing hormone act are both common and distinct Mol. Endocrinol. 8 1994 1038 1048
90. 6)GnRH and antagonist (Antide) Cancer Res. 58 1998 4558 4560
91. S. Kakar W. Grizzle J. Neil The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary Mol. Cell. Endocrinol. 106 1994 145 149
92. S. Kakar L. Jennes Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues Cancer Lett. 98 1995 57 62
93. R. Kapeller L. Cantley Phosphatidylinositol 3-kinase Bioessays 16 1994 565 576
94. A. Kauppila H. Martikainen J. Pentinen M. Reinil GnRH agonist analogue treatment of ovarian granulosa cell malignancies Gynecol. Endocrinol. 4 Suppl. 2 1990 97 98
95. J. Kerr C. Winterford B. Harmon Apoptosis: Its significance in cancer and cancer therapy Cancer 73 1994 2013 2026
96. H.T. Keutmann Receptor-binding regions in human glycoprotein hormones Mol. Cell. Endocrinol. 88 1992 C1 C67
97. A. Khwaja P. Rodriguez-Viciana S. Wennstrom P. Warne J. Downward Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway EMBO J. 16 1997 2783 2793
98. W. King M. Mattaliano T. Chan P. Tsichlis J. Brugge Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation Mol. Cell. Biol. 17 1997 4406 4418
99. D. Kleinman A. Douvdevani A. Schally J. Levy Y. Sharoni Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: Role of apoptosis Am. J. Obstet. Gynecol. 170 1994 96 102
100. R. Kolesnick Z. Fucks Ceramide: A signal for apoptosis or mitogenesis? J. Exp. Med. 181 1995 1949 1952
101. M. Kottler A. Starzec M. Carre J. Lagarde A. Martin R. Counis The genes for gonadotropin-releasing hormone and its receptor are expressed in human breast with fibrocystic disease and cancer Int. J. Cancer 71 1997 595 599
102. L. Krsmanovic S. Stojilkovic L. Mertz M. Tomic K. Catt Expression of gonadotropin-releasing hormone receptors and autocrine regulation of neuropeptide release in immortalized hypothalamic neurons Proc. Natl. Acad. Sci. USA 90 1993 3908 3912
103. S. Kullander Treatment of endometrial cancer with GnRH analogs Recent Results Cancer Res. 124 1992 69 73
104. J. Lacal Regulation of proliferation and apoptosis by Ras and Rho GTPase through specific phospholipid-dependent signaling FEBS Lett. 410 1997 73 77
105. M. Lee C. Liebow A. Kramer A. Schally Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin or phosphorylation and dephosphorylation of tyrosine residues of specific substrates in various tumors Proc. Natl. Acad. Sci. USA 88 1991 1656 1660
106. P. Leung G. Steele Intracellular signaling in the gonads Endocr. Rev. 13 1992 476 498
107. C. Liebow M. Lee A. Kamer A. Schally Regulation of luteinizing hormonereleasing hormone receptor binding by heterologous and autologous receptor-stimulated tyrosine phosphorylation Proc. Natl. Acad. Sci. USA 88 1991 2244 2248
108. P. Limonta D. Dondi R. Moretti R. Maggi M. Motta Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaR J. Clin. Endocrinol. Metab. 75 1992 207 212
109. L. Lin V. Roberts S. Yen Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion J. Clin. Endocrinol. Metab. 80 1995 580 585
110. M. Liscovitch A. Amsterdam Gonadotropin-releasing hormone activates phospholipase D in ovarian granulosa cells J. Biol. Chem. 264 1989 11762 11767
111. M. Liscovitch L. Cantley Lipid second messengers Cell 77 1994 329 334
112. P. Liu R. Anderson Compartmentalized production of ceramide at the cell surface J. Biol. Chem. 270 1995 27179 27185
113. S. Loop C. Gorder S. Lewis R. Dridahl R. Ostenson Growth inhibition of human prostate tumor cells by an agonist of gonadotropin-releasing hormone Prostate 26 1995 179 188
114. P. Maher Activation of phosphotyrosine phosphatase activity by reduction of cellsubstrate adhesion Proc. Natl. Acad. Sci. USA 90 1993 11177 11181
115. P. Majerus Inositol phosphate biochemistry Annu. Rev. Biochem. 61 1992 225 250
116. A. Manni R. Sanren H. Harvey A. Lipton D. Max Treatment of breast cancer with gonadotropin-releasing hormone Endocr Rev. 7 1986 89 113
117. B. Marchetti F. Gallo Z. Farinella C. Tirolo N. Testa C. Romeo M. Morale Luteinizing hormone-releasing hormone is a primary signaling molecule in the neuroimmune network Ann. N.Y. Acad. Sci. 840 1998 205 248
118. L. Marini F. Iacopino G. Schinzari F. Roustelli della Cuna G. Mantovani G. Sica Direct antiproliferative effect of triptorelin on human breast cancer cells Anticancer Res. 14 1994 1881 1886
119. A. Martin K. Saqib M. Hodgkin F. Brown T. Pettit S. Armstrong M. Wakelam Role and regulation of phospholipase D signalling Biochem. Soc. pans. 25 1997 1157 1160
120. M. Martinez-Lorenzo M. Alava A. Piñeiro J. Naval Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells Immunology 89 1996 511 517
121. W. Mason S. Skidar Characterization of voltage-gated sodium channels in ovine gonadotrophs: Relationship to hormone secretion J. Physiol. 399 1988 493 551
122. S. Mathias L. Peǹa R. Kolesnick Signal transduction of stress via ceramide Biochem. J. 335 1998 465 480
123. A.J. Merrill E. Schmelz D. Dillehay S. Spiegel J. Shayman J. Schroeder R. Riley K. Voss E. Wang Sphingolipids-The enigmatic lipid class: Biochemistry, physiology, and pathophysiology Toxicol. Appl. Pharmacol. 142 1997 208 225
124. G. Miller J. Alexander A. Klibanski Gonadotropin-releasing hormone messenger RNA expression in gonadotroph tumors and normal human pituitary J. Clin. Endocrinol. Metab. 81 1996 80 83
125. D. Minaretzis M. Jakubowski J. Mortola S. Pavlou Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells J. Clin. Endocrinol. Metab. 80 1995 430 434
126. T. Mizutani A. Sugihara K. Nakamuro N. Terada Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate) J. Clin. Endocrinol. Metab. 83 1998 1253 1255
127. s6k-dependent pathway Cancer Res. 58 1998 5239 5247
128. A. Morris S. Hammond C. Colley T. Sung J. Jenco V. Sciorra S. Rudge M. Frohman Regulation and functions of phospholipase D Biochem. Soc. Pans. 25 1997 1151 1157
129. P. Müllen W. Scott W. Miller Growth inhibition observed following administration of an LHRH agonist to a clonal variant of the MCF-7 breast cancer cell line is accompanied by an accumulation of the cells in the G0/G1 phase of the cell cycle Br. J. Cancer 63 1991 930 932
130. G. Müller M. Ayoub P. Storz J. Rennecke D. Fabbro K. Pfizenmaier PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid EMBO J. 14 1995 1961 1969
131. S. Nagata Apoptosis by death factor Cell 88 1997 355 365
132. S. Nagata P. Goldstein The Fas death factor Science 267 1995 1449 1456
133. 2∗ mobilizing hormones: The case of gonadotropin-releasing hormone Endocr. Rev. 11 1990 326 353
134. 2∗ and protein kinase C Front. Neuroendocrinol. 19 1998 1 19
135. E.J. Neer Heterotrimeric G proteins: Organizers of transmembrane signals Cell 80 1995 249 257
136. Y. Nishizuka Protein kinase C and lipid signaling for sustained cellular responses FASEB J. 9 1995 197 205
137. T. Ohno A. Imai T. Furui K. Takahashi T. Tamaya Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma Am. J. Obstet. Gynecol. 169 1993 605 610
138. G. Oxford A. Tse Modulation of ion channels underlying excitation-secretion coupling in identified lactotrophs and gonadotrophs Biol. Reprod. 48 1993 1 7
139. M.G. Pan T. Florio P.J.S. Stork G protein activation of a hormone-stimulated phosphatase in human tumor cells Science 256 1992 1215 1217
140. 6-LHRH (decapeptyl) microcapsules Biomed. Pharmacother 42 1988 531 538
141. T. Patel G. Gores S. Kaufmann The role of proteases during apoptosis FASEB J. 10 1996 587 597
142. C. Peng N. Fan M. Ligier J. Vaananen P. Leung Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells Endocrinology 135 1994 1740 1746
143. C. Peterson S. Zimninski Along acting gonadotropin-releasing hormone agonist inhibits the growth of a human epithelial ovarian carcinoma (BG-1) heterotransplanted in the nude mouse Obstet. Gynecol. 76 1990 264 267
144. L. Pike Phosphatidylinositol 4-kinases and the role of polyphosphoinositides in cellular regulation Endocr. Rev. 13 1992 692 707
145. S. Pyne D. Tolan A. Conway N. Pyne Sphingolipids as differential regulators of cellular signalling processes Biochem. Soc. Trans. 25 1997 549 556
146. A. Raid B. Oliver A. Abdelrahman R. Sha'afi J. Hajjar Role of tyrosine kinase and phosphotyrosine phosphatase in growth of the intestinal crypt cell (IEC6) line Proc. Soc. Exp. Biol. Med. 202 1993 435 439
147. M. Raines R. Kolesnick D. Golde Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL60 cells J. Biol. Chem. 268 1993 14572 14575
148. S. Roseff L. Kettel J. Rivier H. Burger E. Baulieu S. Yen Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women Fertil. Steril. 54 1990 805 810
149. R. Runic C.J. Lockwood Y. Ma B. Dipasquale S. Guller Expression of Fas ligand by human cytotrophoblasts: Implications in placentation and fetal survival J. Clin. Endocrinol. Metab. 81 1996 3119 3122
150. N. Sanno L. Jin X. Qian R. Osamura B. Scheithauer K. Kovacs R. Lloyd Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor messenger ribonucleic acids expression in nontumorous and neoplastic pituitaries J. Clin. Endocrinol. Metab. 82 1997 1974 1982
151. P. Santana L. Llanes I. Hernandez G. Gallardo J. Quintana J. Gonzalez F. Estevez C. Ruiz de Galarreta L. Fanjul Ceramide mediates tumor necrosis factor effects on P450-aromatase activity in cultured granulosa cells Endocrinology 136 1995 2345 2348
152. P. Santana L. Llanes I. Hernandez I. Gonzalez-Robayna C. Tabraue J. GonzalezReyes J. Quintana F. Estevez C. Ruiz de Galarreta L. Fanjul Interleukin-1 beta simulates sphingomyelin hydrolysis in cultured granulosa cells: Evidence for a regulatory role of ceramide on progesterone and prostaglandin biosynthesis Endocrinology 137 1996 2480 2489
153. T. Sato S. Irie S. Kitada J. Reed FAP-1: A protein tyrosine phosphatase that associates with Fas Science 268 1995 411 415
154. A. Schally Hypothalamic hormones: From neuroendocrinology to cancer therapy Anticancer Drugs 5 1994 115 130
155. K. Schulze-Osthoff H. Walczak W. Dröge P. Krammer Cell nucleus and DNA fragmentation are not required for apoptosis J. Biol. Chem. 127 1994 15 20
156. R. Schwartzman J. Cidlowski Apoptosis: The biochemistry and molecular biology of programmed cell death Endocr. Rev. 14 1993 133 151
157. S. Sealfon R. Millar Functional domains of the gonadotropin-releasing hormone receptor Cell. Mol. Neurobiol. 15 1995 25 42
158. S. Sealfon H. Weinstein R. Millar Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor Endocr. Rev. 18 1997 180 205
159. Y. Sharoni E. Bosin M. Levy A. Schally Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone Proc. Natl. Acad. Sci. USA 86 1989 1648 1651
160. N. Sherwood D. Lovejoy I. Coe Origin of mammalian gonadotropin-releasing hormones Endocr. Rev. 14 1993 241 254
161. G. Sica F. Iacopino G. Robustelli della Cuna P. Marchetti L. Maini Combined effects of estradiol, leuprorelin, tamoxifen, and medroxyprogesterone acetate on cell growth and steroid receptors in breast cancer cells J. Cancer Res. Clin. Oncol. 120 1994 605 609
162. W. Singer H. Brown P. Sternweise Regulation of eukaryotic phosphatidylinositol-specific phospholipase C and phospholipase D Annu. Rev. Biochem. 66 1997 475 509
163. A. Sinha Hikim T. Rajavashisth I. Sinha Hikim Y. Lue J. Bonavera A. Leung C. Wang R. Swerdloff Significance of apoptosis in the temporal and stage-specific loss of germ cells in the adult rat after gonadotropin deprivation Biol. Reprod. 57 1997 1193 1201
164. A. Spiegel A. Shenker L. Weinstein Receptor-effector coupling by G proteins: Implications for normal and abnormal signal transduction Endocr. Rev. 13 1992 536 565
165. S. Spiegel A.J. Merrill Sphingolipid metabolism and cell growth regulation FASEB J. 10 1996 1388 1397
166. L. Stephens T. Jackson P. Hawkins Agonist-stimulated synthesis of phosphatidylinositol (3,4,5)-trisphosphate: Anew intracellular signalling system? Biochim. Biophys. Acta 1179 1993 27 75
167. S. Stojilkovic S. Izumi K. Catt Participation of voltage-sensitive calcium channels in pituitary hormone secretion J. Biol. Chem. 263 1988 13054 13061
168. S.S. Stojilkovic J. Reinhart K.J. Catt Gonadotropin-releasing hormone receptors: Structure and signal transduction pathways Endocr. Rev. 15 1994 462 499
169. C.D. Strader T.M. Fong M.R. Tota D. Underwood R.A.F. Dixon Structure and function of G protein-coupled receptors Annu. Rev. Biochem. 63 1994 101 132
170. T. Suda T. Takahashi P. Goldstein S. Nagata Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family Cell 75 1993 1169 1178
171. H. Takagi A. Imai T. Furui S. Horibe T. Fuseya T. Tamaya Evidence for tight coupling of gonadotropin-releasing hormone receptors to phosphatidylinositol kinase in plasma membrane from ovarian carcinomas Gynecol. Oncol. 58 1995 110 115
172. H. Takebayashi H. Oida K. Fujisawa M. Yamaguchi T. Hikida M. Fukumoto S. Narumiya A. Kakizuka Hormone-induced apoptosis by Fas-nuclear receptor fusion proteins: Novel biological tools for controlling apoptosis in vivo Cancer Res. 56 1996 4164 4170
173. M. Tanaka T. Suda T. Takahashi S. Nagata Expression of the functional soluble form of human fas ligand in activated lymphocytes EMBO J. 14 1995 1129 1135
174. J. Tapanainen J. Tilly K. Vihko A. Hsueh Hormonal control of apoptotic cell death in the testis: Gonadotropins and androgens as testicular cell survival factors Mol. Endocrinol. 7 1993 643 650
175. R. Testi Sphingomyelin breakdown and cell fate Trends Biochem. Sci. 21 1996 468 471
176. C. Thompson Apoptosis in the pathogenesis and treatment of disease Science 267 1995 1456 1462
177. C. Vlahos W. Matter K. Hui R. Brown A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4 H -1-benzopyran-4-one (LY294002) J. Biol. Chem. 269 1994 5241 5248
178. K. Walton J. Dixon Protein tyrosine phosphatases Anna. Rev. Biochem. 62 1993 101 120
179. T. Wieder C. Geilen T. Kolter F. Sadeghlar K. Sandhofl R. Brossmer P. Ihrig D. Perry C. Orfanos Y. Hannun Bcl-2 antagonizes apoptotic cell death induced by two new ceramide analogues FEBS Lett. 411 1997 260 264
180. J. Witty J. Bridgham A. Johnson Induction of apoptotic cell death in hen granulosa cells by ceramide Endocrinology 137 1996 5269 5277
181. T. Yano J. Pinski G. Halmos K. Szepeshazi K. Groot A. Schally Inhibition of growth of OV 1063 human epithelial ovarian cancer xenografted in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75 Proc. Natl. Acad. Sci. USA 91 1994 7090 7094
182. T. Yano J. Pinski K. Szepeshazi G. Halmos S. Radulovic K. Groot A. Schally Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice Cancer 73 1994 1229 1238
183. B. Yao Y. Zhang S. Delikat S. Mathias S. Basu R. Kolesnick Ceramide-activated protein kinase is a Raf kinase Nature 378 1995 22689 22692
184. H. Yin K. Cheng H. Hwa C. Peng N. Auersperg P. Leung Expression of the messenger RNA for gonadotropin-releasing hormone and its receptor in human cancer cell lines Life Sci. 62 1998 2015 2023
185. S. Yonehara A. Ishii M. Yonehara A cell-killing monoclonal antibody (antiFas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor J. Exp. Med. 169 1989 1747 1756
186. L. Zheng S. Stojilkovic L. Hunyady L. Krsmanovic K. Catt Sequential activation of phospholipase C and phospholipase D in agonist-stimulated gonadotrophs Endocrinology 134 1994 1446 1454